Splenectomy for hereditary spherocytosis: complete, partial or not at all?

References

• Bolton-Maggs PH, Stevens RF, Dodd NJ et al. General Haematology Task Force of the British Committee for Standards in Haematology. Guidelines for the diagnosis and management of hereditary spherocytosis. Br. J. Haematol.126(4), 455–474 (2004).
   PubMed Web of Science ®Google Scholar
• Perrotta S, Gallagher PG, Mohandas N. Hereditary spherocytosis. Lancet372(9647), 1411–1426 (2008).
   PubMed Web of Science ®Google Scholar
• Schilling RF. Risks and benefits of splenectomy versus no splenectomy for hereditary spherocytosis – a personal view. Br. J. Haematol.145(6), 728–732 (2009).
   PubMedGoogle Scholar
• Abdullah F, Zhang Y, Camp M et al. Splenectomy in hereditary spherocytosis: review of 1,657 patients and application of the pediatric quality indicators. Pediatr. Blood Cancer52(7), 834–837(2009).
   PubMedGoogle Scholar
• Price VE, Dutta S, Blanchette VS et al. The prevention and treatment of bacterial infections in children with asplenia or hyposplenia: practice considerations at the Hospital for Sick Children, Toronto. Pediatr. Blood Cancer46(5), 597–603 (2006).
   PubMed Web of Science ®Google Scholar
• Kyaw MH, Holmes EM, Toolis F et al. Evaluation of severe infection and survival after splenectomy. Am. J. Med.119, 276e1–276e7 (2006).
   Google Scholar
• Grace RF, Mednick RE, Neufeld EJ. Compliance with immunizations in splenectomized individuals with hereditary spherocytosis. Pediatr. Blood Cancer52(7), 865–867 (2009).
   PubMedGoogle Scholar
• Thomsen RW, Schoonen WM, Farkas DK et al. Risk for hospital contact with infection in patients with splenectomy: a population-based cohort study. Ann. Intern. Med.151(8), 546–555 (2009).
   PubMed Web of Science ®Google Scholar
• Kaplinsky C, Spirer Z. Post-splenectomy antibiotic prophylaxis – unfinished story: to treat or not to treat? Pediatr. Blood Cancer47(5 Suppl.), 740–741 (2006).
   PubMed Web of Science ®Google Scholar
• Davies JM, Barnes R, Milligan D. Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Clin. Med.2, 440–443 (2002).
   PubMed Web of Science ®Google Scholar
• Stoehr GA, Rose MA, Eber SW et al. Immunogenicity of sequential pneumococcal vaccination in subjects splenectomised for hereditary spherocytosis. Br. J. Haematol.132, 788–790 (2006).
   PubMedGoogle Scholar
• Crary SE, Buchanan GR. Vascular complications after splenectomy for hematologic disorders. Blood114(14), 2861–2868 (2009).
   PubMed Web of Science ®Google Scholar
• Schilling RF, Gangnon RE, Traver M. Arteriosclerotic events are less frequent in persons with chronic anemia: evidence from families with hereditary spherocytosis. Am. J. Hematol.81(5), 315–317 (2006).
   PubMedGoogle Scholar
• Mohren M, Markmann I, Dworschak U et al. Thromboembolic complications after splenectomy for hematologic diseases. Am. J. Hematol.76, 143–147 (2004).
   PubMed Web of Science ®Google Scholar
• Brink JS, Brown AK, Palmer BA et al. Portal vein thrombosis after laparoscopy-assisted splenectomy and cholecystectomy. J. Pediatr. Surg.38, 644–647 (2003).
   PubMedGoogle Scholar
• van’t Riet M, Burger JW, van Muiswinkel JM et al. Diagnosis and treatment of portal vein thrombosis following splenectomy. Br. J. Surg.87, 1229–1233 (2000).
   PubMed Web of Science ®Google Scholar
• Schilling RF, Gangnon RE, Traver MI. Delayed adverse vascular events after splenectomy in hereditary spherocytosis. J. Thromb. Haemost.6, 1289–1295 (2008).
   PubMedGoogle Scholar
• Jaïs X, Ioos V, Jardim C et al. Splenectomy and chronic thromboembolic pulmonary hypertension. Thorax60(12), 1031–1034 (2005).
   PubMed Web of Science ®Google Scholar
• Bonderman D, Jakowitsch J, Adlbrecht C, et al. Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension. Thromb. Haemost.93(3), 512–516 (2005).
   PubMed Web of Science ®Google Scholar
• Lang I, Kerr K. Risk factors for chronic thromboembolic pulmonary hypertension. Proc. Am. Thorac. Soc.3(7), 568–570 (2006).
   PubMedGoogle Scholar
• Suntharalingam J, Machado RD, Sharples LD et al. Demographic features, BMPR2 status and outcomes in distal chronic thromboembolic pulmonary hypertension. Thorax62(7), 617–622 (2007).
   PubMed Web of Science ®Google Scholar
• Bonderman D, Skoro-Sajer N, Jakowitsch J et al. Predictors of outcome in chronic thromboembolic pulmonary hypertension. Circulation115(16), 2153–2158 (2007).
   PubMed Web of Science ®Google Scholar
• Morinis J, Dutta S, Blanchette V et al. Laparoscopic partial vs total splenectomy in children with hereditary spherocytosis. J. Pediatr. Surg.43(9), 1649–1652 (2008).
   PubMedGoogle Scholar
• Rescorla FJ, West KW, Engum SA et al. Laparoscopic splenic procedures in children: experience in 231 children. Ann. Surg.246, 683–687 (2007).
   PubMed Web of Science ®Google Scholar
• Rescorla FJ, Engum SA, West KW et al. Laparoscopic splenectomy has become the gold standard in children. Am. Surg.68, 297–301 (2002).
   PubMedGoogle Scholar
• Feldman LS, Demyttenaere SV, Polyhronopoulos GN et al. Refining the selection criteria for laparoscopic versus open splenectomy for splenomegaly. J. Laparoendosc. Adv. Surg. Tech. A.18(1), 13–19 (2008).
   PubMedGoogle Scholar
• Tchernia G, Gauthier F, Mielot F et al. Initial assessment of the beneficial effect of partial splenectomy in hereditary spherocytosis. Blood81, 2014–2020 (1993).
   PubMed Web of Science ®Google Scholar
• Rice HE, Oldham KT, Hillery CA et al. Clinical and hematologic benefits of partial splenectomy for congenital hemolytic anemias in children. Ann. Surg.237, 281–288 (2003).
   PubMed Web of Science ®Google Scholar
• Stoehr GA, Sobh JN, Luecken J et al. Near-total splenectomy for hereditary spherocytosis: clinical prospects in relation to disease severity. Br. J. Haematol.132, 791–793 (2006).
   PubMedGoogle Scholar
• Bader-Meunier B, Gauthier F, Archambaud F et al. Long-term evaluation of the beneficial effect of subtotal splenectomy for management of hereditary spherocytosis. Blood97, 399–403 (2001).
   PubMedGoogle Scholar
• de Buys Roessingh AS, de Lagausie P, Rohrlich P, Berrebi D, Aigrain Y. Follow-up of partial splenectomy in children with hereditary spherocytosis. J. Pediatr. Surg.37(10), 1459–1463 (2002).
   PubMedGoogle Scholar
• Jabali Y, Smrcka V, Chromcak F, Bäumelt V, Louda V. Ten-year experience with partial splenectomy (PSX) for hereditary spherocytosis (HS) in children [abstract]. Haematologica92(Suppl. 1), 289 (2007).
   PubMedGoogle Scholar
• Dutta S, Price VE, Blanchette V et al. A laparoscopic approach to partial splenectomy for children with hereditary spherocytosis. Surg. Endosc.20, 1719–1724 (2006).
   PubMedGoogle Scholar
• Freud E, Cohen IJ, Mor C et al. Splenic “regeneration” after partial splenectomy for Gaucher disease: histological features. Blood Cells Mol. Dis.24, 309–316 (1998).
   PubMedGoogle Scholar
• Hollingsworth CL, Rice HE. Hereditary spherocytosis and partial splenectomy in children: review of surgical technique and the role of imaging. Pediatr. Radiol.40(7), 1177–1183 (2010).
   PubMedGoogle Scholar
• Vasilescu C, Stanciulea O, Tudor S et al. Laparoscopic subtotal splenectomy in hereditary spherocytosis: to preserve the upper or the lower pole of the spleen? Surg. Endosc.20(5), 748–752 (2006).
   PubMed Web of Science ®Google Scholar
• Slater BJ, Chan FP, Davis K et al. Institutional experience with laparoscopic partial splenectomy for hereditary spherocytosis. J. Pediatr. Surg.45(8), 1682–1686 (2010).
   PubMedGoogle Scholar
• Szabo G, Miko I, Nagy P et al. Adhesion formation with open vs laparoscopic cholecystectomy: an immunologic and histologic study. Surg. Endosc.21, 253–257 (2007).
   PubMedGoogle Scholar
• Iolascon A, Faienza MF, Moretti A, Perrotta S, Miraglia del Giudice E. UGT1 promoter polymorphism accounts for increased neonatal appearance of hereditary spherocytosis. Blood91, 1093 (1998).
   PubMedGoogle Scholar
• Berardi A, Lugli L, Ferrari F et al. Kernicterus associated with hereditary spherocytosis and UGT1A1 promoter polymorphism. Biol. Neonate90, 243–246 (2006).
   PubMedGoogle Scholar
• Marchetti M, Quaglini S, Barosi G. Prophylactic splenectomy and cholecystectomy in mild hereditary spherocytosis: analyzing the decision in different clinical scenarios. J. Int. Med.244, 217–226 (1998).
   PubMedGoogle Scholar
• Alizai NK, Richards EM, Stringer MD. Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Arch. Dis. Child.95(8), 596–599 (2010).
   PubMedGoogle Scholar
• Sandler A, Winkel G, Kimura K et al. The role of prophylactic cholecystectomy during splenectomy in children with hereditary spherocytosis. J. Pediatr. Surg.34(7), 1077–1078 (1999).
   PubMedGoogle Scholar
• Hero M, Wickman S, Hanhijärvi R et al. Pubertal upregulation of erythropoiesis in boys is determined primarily by androgen. J. Pediatr.146(2), 245–252 (2005).
   PubMed Web of Science ®Google Scholar
• Halasa NB, Shankar SM, Griffin MR et al. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. Clin. Infect. Dis.44, 1428–1433 (2007).
   PubMed Web of Science ®Google Scholar
• Yeh SH, Gurtman A, Hurley DC et al. Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers. Pediatrics126(3), e493–e505 (2010).
   PubMed Web of Science ®Google Scholar
• Kieninger DM, Kueper K, Steul K et al. Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared with a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany. Vaccine28(25), 4192–4203 (2010).
   PubMed Web of Science ®Google Scholar
• Thompson BW, Miller ST, Rogers ZR, et al. The pediatric hydroxyurea Phase III clinical trial (BABY HUG): challenges of study design. Pediatr. Blood Cancer54(2), 250–255 (2010).
   PubMed Web of Science ®Google Scholar
• Tracy ET, Rice HE. Partial splenectomy for hereditary spherocytosis. Pediatr. Clin. North Am.55(2), 503–519 (2008).
   PubMedGoogle Scholar
• Kruetzmann S, Rosado MM, Weber H, et al. Human immunoglobulin M memory B cell controlling Streptococcus pneumoniae infections are generated in the spleen. J. Exp. Med.197, 939–945 (2003).
   PubMed Web of Science ®Google Scholar
• Di Sabatino A, Rosado MM, Corazza GR et al. Depletion of immunoglobulin M memory B cells is associated with splenic hypofunction in inflammatory bowel disease. Am. J. Gastoenterol.100, 1788–1795 (2005).
   PubMed Web of Science ®Google Scholar
• Vodjgani M, Aghamohammadi A, Samadi M et al. Analysis of class-switched memory B cells in patients with common variable immunodeficiency and its clinical implications. J. Investig. Allergol. Clin. Immunol.17(5), 321–328 (2007).
   PubMed Web of Science ®Google Scholar
• Wasserstrom H, Bussel J, Lim LC et al. Memory B cells and pneumococcal antibody after splenectomy. J. Immunol.181(5), 3684–3689 (2008).
   PubMed Web of Science ®Google Scholar
• Weller S, Braun MC, Tan BK et al. Human blood IgM “memory” B cells are circulating splenic marginal zone B cells harbouring a prediversified immunoglobulin repertoire. Blood104, 3647–3654 (2004).
   PubMed Web of Science ®Google Scholar
• Cariappa A, Chase C, Liu H et al. Naive recirculating B cells mature simultaneously in the spleen and bone marrow. Blood109, 2339–2345 (2007).
   PubMedGoogle Scholar
• Rodgers BM, Tribble C, Joob A. Partial splenectomy for Gaucher’s disease. Ann. Surg.205(6), 693–699 (1987).
   PubMedGoogle Scholar
• Warkentin TE, Barr RD, Ali MA, Mohandas N. Recurrent acute splenic sequestration crisis due to interacting genetic defects: hemoglobin SC disease and hereditary spherocytosis. Blood75(1), 266–270 (1990).
   PubMed Web of Science ®Google Scholar
• Yang YM, Donnell C, Wilborn W et al.Splenic sequestration associated with sickle cell trait and hereditary spherocytosis. Am. J. Hematol.40(2), 110–116 (1992).
   PubMed Web of Science ®Google Scholar